Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholder's Equity

v3.8.0.1
Consolidated Statements of Stockholder's Equity - USD ($)
$ in Thousands
Total
Extab [Member]
LPC [Member]
Common Stock
Common Stock
Extab [Member]
Common Stock
LPC [Member]
Additional paid-in capital [Member]
Additional paid-in capital [Member]
Extab [Member]
Additional paid-in capital [Member]
LPC [Member]
Accumulated other comprehensive income (loss) [Member]
Accumulated deficit [Member]
Beginning Balance at May. 12, 2015 $ 0     $ 0     $ 0     $ 0 $ 0
Beginning Balance, Shares at May. 12, 2015       0              
Common stock issued, Shares       11,730              
Conversion of common stock held by Extab Corporation stockholders into common stock [note 6]   $ 667           $ 667      
Conversion of common stock held by Extab Corporation stockholders into common stock [note 6], Shares         5,000            
Conversion of note payable into common stock [note 6] 2,000           2,000        
Conversion of note payable into common stock [note 6], Shares       4,500              
Net loss (828)                   (828)
Other comprehensive income (loss) 1                 1  
Ending Balance at Dec. 31, 2015 $ 1,840           2,667     1 (828)
Ending Balance, Shares at Dec. 31, 2015       21,230              
Restricted Stock Unit Settlements, Shares 0                    
Net loss $ (1,234)                   (1,234)
Other comprehensive income (loss) 4                 4  
Ending Balance at Dec. 31, 2016 610           2,667     5 (2,062)
Ending Balance, Shares at Dec. 31, 2016       21,230              
Common stock issued     $ 2,306     $ 1     $ 2,305    
Common stock issued, Shares           997,301          
Stock-based compensation expense 348           348        
Settlement of stockholder loans with related parties 2,132           2,132        
Settlement of stockholder loans with related parties, Shares       1,572              
Shares issued on subscription 64           64        
Shares issued on subscription, Shares       48              
Shares held by OncoGenex Shareholders 3     $ 3              
Shares held by OncoGenex Shareholders, Shares       2,736,709              
Shares issued on conversion of Achieve common shares $ 13,048     $ 8     13,040        
Shares issued on conversion of Achieve common shares, Shares       8,210,118              
Shares cancelled on conversion of Achieve common shares       (22,850)              
Restricted Stock Unit Settlements, Shares 5,464     5,464              
Restricted Stock Unit Settlements withheld and retired to treasury $ (5)                   (5)
Restricted Stock Unit Settlements withheld and retired to treasury, Shares       (1,660)              
Purchase accounting adjustment (44)                   (44)
Net loss (10,583)                   (10,583)
Ending Balance at Dec. 31, 2017 $ 7,879     $ 12     $ 20,556     $ 5 $ (12,694)
Ending Balance, Shares at Dec. 31, 2017       11,947,932